Filing Details
- Accession Number:
- 0001689548-21-000003
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-02-16 16:11:59
- Reporting Period:
- 2020-10-20
- Accepted Time:
- 2021-02-16 16:11:59
- Original Submission Date:
- 2020-10-20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1689548 | Praxis Precision Medicines Inc. | PRAX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1826967 | Stefan Vitorovic | C/O Praxis Precision Medicines, Inc. One Broadway, 16Th Floor Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-20 | 2,689,329 | $0.00 | 2,689,329 | No | 4 | C | Indirect | See Footnote |
| Common Stock | Acquisiton | 2020-10-20 | 250,000 | $19.00 | 2,939,329 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See Footnote |
| No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Preferred Stock | Disposition | 2020-10-20 | 4,150,000 | $0.00 | 1,939,295 | $0.00 |
| Common Stock | Series B-1 Preferred Stock | Disposition | 2020-10-20 | 551,794 | $0.00 | 257,853 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2020-10-20 | 171,410 | $0.00 | 80,100 | $0.00 |
| Common Stock | Series C-1 Preferred Stock | Disposition | 2020-10-20 | 881,835 | $0.00 | 412,081 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- All series of Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-2.14 basis upon the closing of the Issuer's initial public offering on October 20, 2020 and had no expiration date.
- These shares are held directly by Vida Ventures, LLC, a United States limited liability company. The Reporting Person is a managing director of Vida Ventures, LLC and is also a member of the board of directors of the Issuer. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest therein, if any.
Billionaire Hedge Funds
